This includes the prescription of drugs approved for the treatment of other diseases such as Hydroxychloroquine, Remdesivir, and Kaletra, for treatment of the coronavirus. The system lets physicians record the patients’ daily progress. By collecting real-world data, “We will quickly discover which of the new drugs are most effective against COVID-19, their optimal dosages, and how early in the disease progression the drugs need to be administered. Doctors and patients began enrolling in the TLS this week and it is available to every physician in the Untied States